🔗 Visit the ClinicalTrials.gov page for NCT01560754
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. | Neurotherapeutics | 2014 | 0.92 |
| 2 | Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. | Pharmacol Ther | 2014 | 0.82 |
| 3 | Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons. | J Neurosci | 2016 | 0.79 |
| 4 | Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations. | Brain Res | 2016 | 0.79 |
| 5 | Therapeutic approaches in Parkinson's disease and related disorders. | J Neurochem | 2016 | 0.78 |
| 6 | Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease. | Curr Neuropharmacol | 2016 | 0.77 |